Catalyst Funds Management Pty LTD Kymera Therapeutics, Inc. Call Options Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KYMR
# of Institutions
185Shares Held
60.3MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$209 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$182 Million2.67% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$157 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$157 Million3.02% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$149 Million32.49% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.66B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...